Short Stature in KBG Syndrome: First Responses to Growth Hormone Treatment.
Horm Res Paediatr
; 83(5): 361-4, 2015.
Article
in En
| MEDLINE
| ID: mdl-25833229
ABSTRACT
BACKGROUND:
KBG syndrome is a rare disorder characterized by intellectual disability and associated with macrodontia of the upper central incisors, specific craniofacial findings, short stature and skeletal anomalies. Genetic corroboration of a clinical diagnosis has been possible since 2011, upon identification of heterozygous mutations in or a deletion of the ANKRD11 gene.METHODS:
We summarized the height data of 14 adults and 18 children (age range 2-16 years) with a genetically confirmed diagnosis of KBG syndrome. Two of these children were treated with growth hormones.RESULTS:
Stature below the 3rd centile or -1.88 standard deviation score (SDS) was observed in 72% of KBG children and in 57% of KBG adults. Height below -2.50 SDS was observed in 62% of KBG children and in 36% of KBG adults. The mean SDS of height in KBG children was -2.56 and in KBG adults -2.17. Two KBG children on growth hormone therapy increased their height by 0.6 and 1 SDS within 1 year, respectively. The former also received a gonadotropin-releasing hormone agonist due to medical necessity.CONCLUSION:
Short stature is prevalent in KBG syndrome, and spontaneous catch-up growth beyond childhood appears limited. Growth hormone intervention in short KBG children is perceived as promising.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tooth Abnormalities
/
Bone Diseases, Developmental
/
Human Growth Hormone
/
Growth Disorders
/
Intellectual Disability
Type of study:
Prognostic_studies
Limits:
Child
/
Humans
/
Male
Language:
En
Journal:
Horm Res Paediatr
Journal subject:
ENDOCRINOLOGIA
/
PEDIATRIA
Year:
2015
Document type:
Article
Affiliation country: